Melanoma :: Scientists harness diptheria toxin and interleukin 2 to help the immune system attack melanoma
Researchers investigating ways of prompting the immune system to recognise and kill tumour cells have found that a drug containing parts of the diptheria toxin appears to work well in patients with advanced melanoma, according to research presented at the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics on Thursday.